Betamethason Sandoz zalf 1 mg/g, hydrofobe zalf Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

betamethason sandoz zalf 1 mg/g, hydrofobe zalf

sandoz b.v. - betamethasonvaleraat; - zalf - betamethasone

Betamethason BModesto emulsie voor cutaan gebruik 1 mg/g Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

betamethason bmodesto emulsie voor cutaan gebruik 1 mg/g

bmodesto b.v. minervaweg 2 8239 dl lelystad - betamethasonvaleraat samenstelling overeenkomend met ; betamethason - emulsie voor cutaan gebruik - cetostearylalcohol ; citroenzuur 1-water (e 330) ; glycerol (e 422) ; isopropylalcohol ; macrogolcetostearylether ; methylparahydroxybenzoaat (e 218) ; paraffine, vloeibaar (e905) ; trinatriumcitraat 2-water (e 331) ; water, gezuiverd ; xanthaangom (e 415) - betamethasone

betamethasone dipropionate- betamethasone dipropionate ointment USA - engelsk - NLM (National Library of Medicine)

betamethasone dipropionate- betamethasone dipropionate ointment

warrick pharmaceuticals corporation - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - ointment - 0.5 mg in 1 g - augmented betamethasone dipropionate ointment is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. augmented betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation.

READYSHARP BETAMETHASONE- betamethasone sodium phosphate and betamethasone acetate injection, suspension USA - engelsk - NLM (National Library of Medicine)

readysharp betamethasone- betamethasone sodium phosphate and betamethasone acetate injection, suspension

terrain pharmaceuticals - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular

Calcipotriol/Betamethason Teva 50 microgram/g + 0,5 mg/g, zalf Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

calcipotriol/betamethason teva 50 microgram/g + 0,5 mg/g, zalf

teva nederland b.v. swensweg 5 2031 ga haarlem - betamethasondipropionaat 0,6 mg/g samenstelling overeenkomend met ; betamethason 0,5 mg/g ; calcipotriol 50 µg/g - zalf - butylhydroxytolueen (e 321) ; paraffine, vloeibaar (e905) ; paraffine, zacht (e 905) ; polyoxypropyleen-15-stearylether, - calcipotriol, combinations

Fusidinezuur/Betamethasone Dermapharm 20 mg/g - 1 mg/g crème Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fusidinezuur/betamethasone dermapharm 20 mg/g - 1 mg/g crème

dermapharm ag - fusidinezuurhemihydraat 20,4 mg/g - eq. fusidinezuur 20 mg/g; betamethasonvaleraat 1,214 mg/g - eq. betamethason 1 mg/g - crème - 20 mg/g - 1 mg/g - fusidinezuurhemihydraat 20.4 mg; betamethasonvaleraat 1.214 mg/g - betamethasone and antibiotics

Betamethason acis Crinale Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

betamethason acis crinale

acis arzneimittel gmbh (8087957) - betamethasonvalerat (ph.eur.) - lösung zur anwendung auf der haut - teil 1 - lösung zur anwendung auf der haut; betamethasonvalerat (ph.eur.) (03381) 1,22 milligramm

Betamethason EXELTIS 1 mg/g Lösung zur Anwendung auf der Haut (Kopfhaut) Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

betamethason exeltis 1 mg/g lösung zur anwendung auf der haut (kopfhaut)

exeltis germany gmbh (8128254) - betamethasonvalerat (ph.eur.) - lösung zur anwendung auf der haut (kopfhaut) - teil 1 - lösung zur anwendung auf der haut (kopfhaut); betamethasonvalerat (ph.eur.) (03381) 1,22 milligramm

Calcipotriol/Betamethason Dermapharm 50 Mikrogramm/g + 0,5 mg/g Salbe Østerrike - tysk - AGES (Agentur für Gesundheit und Ernährungssicherheit)

calcipotriol/betamethason dermapharm 50 mikrogramm/g + 0,5 mg/g salbe

dermapharm ag - betamethason dipropionat; calcipotriol monohydrat -

BETAMETHASONE Schering-Plough 2 mg, comprimé dispersible sécable Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

betamethasone schering-plough 2 mg, comprimé dispersible sécable

schering plough - bétaméthasone - comprimé - 2 mg - composition pour un comprimé > bétaméthasone : 2 mg